These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20636862)

  • 1. The application of molecular structural predictors of intestinal absorption to screening of compounds for transdermal penetration.
    Grice JE; Cross SE; Brownlie C; Roberts MS
    J Pharm Pharmacol; 2010 Jun; 62(6):750-5. PubMed ID: 20636862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the role of different drug transport routes in permeability screening.
    Matsson P; Bergström CA; Nagahara N; Tavelin S; Norinder U; Artursson P
    J Med Chem; 2005 Jan; 48(2):604-13. PubMed ID: 15658873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards a correlation between drug properties and in vitro transdermal flux variability.
    Frum Y; Khan GM; Sefcik J; Rouse J; Eccleston GM; Meidan VM
    Int J Pharm; 2007 May; 336(1):140-7. PubMed ID: 17182201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vesicles as tools for the modulation of skin permeability.
    Dubey V; Mishra D; Nahar M; Jain NK
    Expert Opin Drug Deliv; 2007 Nov; 4(6):579-93. PubMed ID: 17970662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
    Dahan A; Amidon GL
    Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of human pharmacokinetics--gastrointestinal absorption.
    Fagerholm U
    J Pharm Pharmacol; 2007 Jul; 59(7):905-16. PubMed ID: 17637184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and performance of a spreadsheet-based model for estimating bioavailability of chemicals from dermal exposure.
    Dancik Y; Miller MA; Jaworska J; Kasting GB
    Adv Drug Deliv Rev; 2013 Feb; 65(2):221-36. PubMed ID: 22285584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of protein on Caco-2 permeability of low mass balance compounds for absorption projection and efflux substrate identification.
    Liu T; Chang LJ; Uss A; Chu I; Morrison RA; Wang L; Prelusky D; Cheng KC; Li C
    J Pharm Biomed Anal; 2010 Apr; 51(5):1069-77. PubMed ID: 20036089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin electroporation for transdermal and topical delivery.
    Denet AR; Vanbever R; Préat V
    Adv Drug Deliv Rev; 2004 Mar; 56(5):659-74. PubMed ID: 15019751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defense against dermal exposures is only skin deep: significantly increased penetration through slightly damaged skin.
    Nielsen JB; Nielsen F; Sørensen JA
    Arch Dermatol Res; 2007 Nov; 299(9):423-31. PubMed ID: 17882442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled transdermal delivery of model drug compounds by MEMS microneedle array.
    Xie Y; Xu B; Gao Y
    Nanomedicine; 2005 Jun; 1(2):184-90. PubMed ID: 17292077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iontophoretic drug delivery.
    Kalia YN; Naik A; Garrison J; Guy RH
    Adv Drug Deliv Rev; 2004 Mar; 56(5):619-58. PubMed ID: 15019750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport.
    Varma MV; Sateesh K; Panchagnula R
    Mol Pharm; 2005; 2(1):12-21. PubMed ID: 15804173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of epidermal turnover on the dynamics of percutaneous drug absorption.
    Simon L; Kim KS; Kanneganti K
    Math Biosci; 2011 Jan; 229(1):16-21. PubMed ID: 21040736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mathematical and pharmacokinetic modelling of epidermal and dermal transport processes.
    Anissimov YG; Jepps OG; Dancik Y; Roberts MS
    Adv Drug Deliv Rev; 2013 Feb; 65(2):169-90. PubMed ID: 22575500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and therapeutic applications of iontophoresis.
    Sieg A; Wascotte V
    J Drug Target; 2009 Nov; 17(9):690-700. PubMed ID: 19845485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in transdermal drug delivery.
    Subedi RK; Oh SY; Chun MK; Choi HK
    Arch Pharm Res; 2010 Mar; 33(3):339-51. PubMed ID: 20361297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin permeation: the years of enlightenment.
    Hadgraft J; Lane ME
    Int J Pharm; 2005 Nov; 305(1-2):2-12. PubMed ID: 16246513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
    Ottaviani G; Martel S; Carrupt PA
    J Med Chem; 2007 Feb; 50(4):742-8. PubMed ID: 17300161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.